Rapid advances in personalized medicine have sparked interest in another new idea: precision public health.
Essentially, it’s the thought that if doctors could pinpoint populations with genetic vulnerabilities — like those prone to obesity, depression, or cancer — they might be able to treat those diseases sooner, slow their progression, or even prevent them altogether. It could be a more effective preventive medicine tactic than the blanket approaches used right now.
“We are treating to the mean effect,” Donna Arnett, a researcher and the dean of the University of Kentucky College of Public Health, said in a talk Tuesday hosted by the Boston University School of Public Health. “We have to think just beyond the mean.”
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect